Asthma RIPS
-
Upload
muhammad-saalim -
Category
Documents
-
view
219 -
download
0
Transcript of Asthma RIPS
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 1/56
Asthma
•MUHAMMAD SAALIMROLL # S08-54•AMANAT ALIROLL # S08-58
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 2/56
Chronic disease of the airways that maycause Wheezing Breathlessness
Chest tightness Nighttime or early morning coughing
Episodes are usually associated withwidespread, but variable, airflow obstruction
within the lung that is often reversible eitherspontaneously or with treatment.
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 3/56
Chronic inflammatory disorder of the airwaysin which many cells and cellular elements playa role. In susceptible individuals, thisinflammation causes recurrent episodes ofwheezing, breathlessness, chest tightness, andcoughing, particularly at night or in the earlymorning. These episodes are associated withwidespread but variable airflow obstruction
that is reversible either spontaneously, or withtreatment.
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 4/56
1. Intrinsic asthma
2. Extrinsic asthma
3. Nocturnal asthma
4. Bronchial asthma
5. Occupational asthma6. Silent asthma
7. Seasonal asthma Exercise induced
asthma
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 5/56
Genetic characteristics
Occupational exposures Environmental exposures
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 6/56
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 7/56
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 8/56
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 9/56
Three major changes:-Increase mucous production
air tubes clog up-Inflammation of air way cells
air tubes swell-Tightening of muscles around air tubes
Air tubes narrowing & hard to breathe
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 10/56
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 11/56
medical emergency
life-threatening episode of airway obstruction
an acute exacerbation of asthma that does not
respond to standard treatments ofbronchodilators and steroids.
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 12/56
Same symptoms as in normal asthma attack
Complications include cardiac and/or respiratoryarrest.
The lung failure means that oxygen can no longer beprovided, carbon dioxide can no longer beeliminated, which leads to acidosis.
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 13/56
PFT (Pulmonary Function Test) FEV (forced expiratory volume)
The volume of air that can be forced out taking a deebreath, an important measure of pulmonary function
3. PFR (Peak flow rate) FVC Forced Vital Capacity (FVC) is the volume
of air that can forcibly be blown out after
full inspiration, measured in liters.
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 14/56
PEF(PEF) is the maximal flow (or speed) achieved during themaximally forced expiration initiated at full inspiration, measuredin liters per minute.
Tidal volume (TV) Tidal volume (TV) is the specific volume of air drawn into, and
then expired out of, the lungs during normal tidal breathing. Total Lung Capacity (TLC) Total Lung Capacity (TLC) is the maximum volume of air present
in the lungs. Residual volume: Amount of air that stays in the lungs even after
max. expiration.
Step up: If uncontrolled at any severity level, oral steroids Step down: When stable for at least 3 months – reduce or stop oral steroids first.
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 15/56
Measurement Approximate Value
Males Females
Forced VitalCapacity (FVC)
4.8 L 3.7 L
Tidal volume
(Vt)
500 ml 390 ml
Total lung capacity(TLC)
6 L 4.7 L
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 16/56
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 17/56
Symptoms Coughing
Wheezing
Shortness of breath Chest tightness
Symptom Patterns
Severity
Family History
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 18/56
Troublesome cough, particularly at night Awakened by coughing
Coughing or wheezing after physical
activity Breathing problems during particular
seasons
Coughing, wheezing, or chest tightnessafter allergen exposure
Colds that last more than 10 days
Relief when medication is used
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 19/56
Wheezing sounds during normalbreathing
Hyperexpansion of the thorax
Increased nasal secretions or nasalpolyps
Atopic dermatitis, eczema, or otherallergic skin conditions
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 20/56
Peak expiratory flow (PEF)
Inexpensive
Patients can use at home
May be helpful for patients with severe diseaseto monitor their change from baseline everyday
Not recommended for all patients with mild or
moderate disease to use every day at home
Effort and technique dependent
Should not be used to make diagnosis of asthma
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 21/56
Allows patient to assess status of his/her asthma Persons who use peak flow meters should do so frequently
Many physicians require for all severe patients
Zone Reading Description
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 22/56
Zone Reading Description
Green 71-100%of normal
PFR
Asthma is under good control.
Yellow 50-70% of normal PFR
Indicates caution. It may meanrespiratory airways are narrowing
and additional medication may berequired
Red <50%
normal PFR
Indicates a medical emergency.
Severe airway narrowing may beoccurring and immediate actionneeds to be taken. This wouldusually involve contacting a doctoror hospital.
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 23/56
Spirometry
Recommended to do spirometry pre- and post- useof an albuterol MDI to establish reversibility ofairflow obstruction
> 12% reversibility or an increase in FEV1 of 200cc isconsidered significant
Obstructive pattern: reduced FEV1/FVC ratio
Restrictive pattern: reduced FVC with a normalFEV1/FVC ratio
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 24/56
Spirometry
Can be used to identify reversible airway obstructiondue to triggers
Can diagnose Exercise-induced asthma (EIA) orExercise-induced bronchospasm (EIB) by measuringFEV1/FVC before exercise and immediatelyfollowing exercise, then for 5-10 minute intervalsover the next 20-30 minutes looking for post-exercise
bronchoconstriction
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 25/56
Methacholine challenge
Most common bronchoprovocative test in US
Patients breathe in increasing amounts of
methacholine and perform spirometry after eachdose
Increased airway hyperresponsiveness is establishedwith a 20% or more decrease in FEV1 from baselineat a concentration < 8mg/dl
May miss some cases of exercise-induced asthma
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 26/56
Diagnostic trial of anti-inflammatorymedication (preferably corticosteroids) or aninhaled bronchodilator
Especially helpful in very young children unable tocooperate with other diagnostic testing
There is no one single test or measure that candefinitively be used to diagnose asthma in every
patient
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 27/56
Mild (no Mod (may need Severe (need
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 28/56
Mild (noadmission)
Mod (may needadmission)
Severe (needadmission)
Alteredconsciousness
No No Yes
Physicalexhaustion
No No Yes
Talks in Sentence Phrases Words
Pulsus
paradoxusNot palpable May be
palpablePalpable
Wheeze onascultation
Present Present Silent chest
Use of accessorymuscles
Absent Moderate Marked
SaO2 >93% 91-93% 90% & <
PFR >60% 40-60% <40%
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 29/56
Medications come in several forms.
Two major categories ofmedications are: Long-term control Quick relief
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 30/56
Taken daily over a long period of time
Used to reduce inflammation, relax airway
muscles, and improve symptoms and lungfunction
Inhaled corticosteroids
Long-acting beta2
-agonists
Leukotriene modifiers
Mast cell stablizer
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 31/56
Used in acute episodes
Generally short-actingbeta2agonists
Anticholinergic drug
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 32/56
Butekyo Method
Simple breathing technique
Studied in many clinical trials
No side effects
Brochial Thermoplasty
Deliver thermal energy to airway walls
Smoking
Weight Reduction
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 33/56
Achieve and maintain control of symptoms
Maintain normal activity levels, including
exercise Maintain pulmonary function as close to
normal levels as possible Prevent asthma exacerbations
Avoid adverse effects from asthmamedications
Prevent asthma mortality
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 34/56
Develop with a physician
Tailor to meet individual needs
Educate patients and families about allaspects of plan Recognizing symptoms
Medication benefits and side effects Proper use of inhalers and Peak Expiratory Flow
(PEF) meters
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 35/56
Describes medicinesto use and actions
to take
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 36/56
(ADULTS)
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 37/56
Peak flow >50-75% of predicted or best
No features of acute severe asthma
Increasing symptoms
Treat at home but response to t/m must beassessed before doctor leaves
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 38/56
Treatment:
High-flow oxygen if available
Salbutamol or terbutaline via large volume
spacer (4-6puffs each inhaled separately; doserepeated every 10-20min if necessary) ornebuliser
Monitor response 15-30min after nebulisation
Give oral prednisolone 40-50mg daily foratleast 5days and step up usual t/m.
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 39/56
Follow up:
Monitor symptoms and peak flow
Set up asthma action plan
Review in surgery within 48hrs
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 40/56
Cannot complete sentences in one breath
Pulse > 110 beats/min
Respiration > 25 breaths/min
Peak flow 33-50% of predicted or best
Seriously consider hospital admission if morethan one of above features present.
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 41/56
Treatment:
High flow oxygen if available
Salbutamol or terbutaline via large volumespacer (4-6puffs each inhaled separately; doserepeated every 10-20min if necessary) or nebuliser(oxygen driven)
Oral prednisolone 40-50mg daily for atleast 5days(or IV hydrocortisone 400mg daily in 4 divideddoses)
Monitor response 15-30min after nebulisation
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 42/56
If any signs of acute asthma persist:
Arrange hospital admission
While awaiting ambulance repeat nebulised beta 2agonist and give with nebulised ipratropium 500ug .
If symptoms have improved, respiration and pulsesetting and peak flow >50%:
Step up usual t/m & continue prednisolone foratleast 5days.
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 43/56
Follow up:
Monitor symptoms and peak flow
Set up asthma action plan
Review in surgery within 24hrs
Modify t/m a review
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 44/56
Silent chest
Cyanosis
Feeble respiratory effort (slow)
Bradycardia, exhaustion, arrythmias,hypotension, confusion or coma
Peak flow <33% of predicted or best
Arterial oxygen saturation <92%.
Arrange immediate hospital admission
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 45/56
Treatment:
Oral prednisolone 40-50mg daily for atleast 5days(or IV hydrocortisone 400mg daily in 4 divided
doses) (immediately) Oxygen driven nebuliser in ambulance
Nebulised beta 2 agonist with nebulisedipratropium
Stay with patient until the ambulance arrives
If nebuliser not available, give 1puff of beta 2agonist using large volume spacer and repeat 10-
20 times.
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 46/56
Imp:
patients with severe or life threatening attacksmay not be distressed and may not have all
these abnormalities, the presence of any shouldalert the doctor.
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 47/56
(CHILDREN)
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 48/56
Too breathless to talk
Too breathless to feed
R/R 50 b/min
Use of accessory muscles of respiration
PFR < 50%
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 49/56
Cyanosis
Silent chest
Poor respiratory effort
Exhaustion
Reduced level of consciousness
PFR < 33%
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 50/56
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 51/56
DIPS [Dosage, Instructions,Priming, Special
Instructions]D:
Is the patient going to be using 1 or 2 inhalations?If a bronchodilator and maintenance medications
are prescribed.I:
The instructions can vary according to whichdelivery system is being used.
P:2 to 4 sprays in the air
S:(eg, some are breath-actuated, and some require
capsules to be inserted into the device).
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 52/56
The health-care providershould evaluate inhaler
technique at each visit.
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 53/56
Spacers can help patients
who have difficulty withinhaler use and can reducepotential for adverse effectsfrom medication
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 54/56
Machine produces a mist ofthe medication
Used for small children orfor severe asthma episodes
No evidence that it is moreeffective than an inhalerused with a spacer
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 55/56
ANY
QUESTIONS???
8/2/2019 Asthma RIPS
http://slidepdf.com/reader/full/asthma-rips 56/56